Search - tctmd.com

Displaying 321 - 340 of 4093

Sort: Relevancy | Date

Presentation TCT 2024

TCT 307: Temporal Trends in Mortality Related to Stroke and Atrial Fibrillation in the United States: A 21-Year Retrospective Analysis of CDC-WONDER Database

Presenter: Hanzala Farooqi

October 29, 2024

Presentation TCT 2024

TCT 308: Colchicine for the Prevention of Recurrent Non-Cardioembolic Stroke: A Meta-Analysis of Randomized Controlled Trials

Presenter: Michael Sabina

October 29, 2024

Presentation TCT 2024

TCT 311: Identifying Success Factors for Patent Foramen Ovale Closure in Cryptogenic Stroke

Presenter: Yoonsun Won

October 29, 2024

Presentation TCT 2024

TCAR: Is Real World Data in Sync with Trial Data?

Presenter: Peter Schneider

October 29, 2024

Presentation TCT 2024

The Significance of Advocacy in Shaping Health Justice for PAD-CLTI Care

Presenter: Foluso Fakorede

October 29, 2024

Presentation TCT 2024

Does Specialty-Based Treatment Bias Impact Outcomes in CLTI?

Presenter: Teresa Carman

October 29, 2024

Presentation TCT 2024

What Impact Do Social Determinants Have on CLTI Care, and What Strategies Can Be Implemented for Improvement?

Presenter: Kim Smolderen

October 29, 2024

Presentation TCT 2024

Addressing Regional Disparities to Improve Access to Care for CLTI Patients

Presenter: Alexander Fanaroff

October 29, 2024

Presentation TCT 2024

Latest Advancements in the Best CLI-Basil Patient Journey

Presenter: Matthew Menard

October 29, 2024

Presentation TCT 2024

Implementation Science in PAD Intervention: Optimize PAD

Presenter: Gregory Piazza

October 29, 2024

Presentation TCT 2024

Designing Future RCTs in PAD Intervention to Meaningfully Change Hard Endpoints - The "Just Give It" Approach

Presenter: Marc Bonaca

October 29, 2024

Presentation TCT 2024

Insights from VOYAGER PAD on Anticoagulants in PVI Patients

Presenter: R. Kevin Rogers

October 29, 2024

Presentation TCT 2024

Early Lipid Lowering Therapy and Glycemic Control Agents: What’s Their Benefit in PAD Intervention

Presenter: Naomi Hamburg

October 29, 2024

Presentation TCT 2024

Real World Data in PAD

Presenter: Eric Secemsky

October 29, 2024

Presentation TCT 2024

Best CLI Medical Therapy Subgroup

Presenter: Matthew Menard

October 29, 2024

Presentation TCT 2024

Peerless Trial Pivotal Results

Presenter: Wissam Jaber

October 29, 2024

Presentation TCT 2024

What am I Most Anticipating in Upcoming Clinical Trials?

Presenter: Eric Secemsky

October 29, 2024

Presentation TCT 2024

Most Important Clinical Trial Endpoints to the PE Clinician in the Trenches

Presenter: Behnood Bikdeli

October 29, 2024

Presentation TCT 2024

Peerless Digging Through the Supplement

Presenter: Jay Giri

October 29, 2024

Presentation TCT 2024

Interpreting the PEERLESS Trial Through the Statistical Lens

Presenter: Alexandra Lansky

October 29, 2024

Advertisement

TCT 307: Temporal Trends in Mortality Related to Stroke and Atrial Fibrillation in the United States: A 21-Year Retrospective Analysis of CDC-WONDER Database

TCT 308: Colchicine for the Prevention of Recurrent Non-Cardioembolic Stroke: A Meta-Analysis of Randomized Controlled Trials

TCT 311: Identifying Success Factors for Patent Foramen Ovale Closure in Cryptogenic Stroke

TCAR: Is Real World Data in Sync with Trial Data?

The Significance of Advocacy in Shaping Health Justice for PAD-CLTI Care

Does Specialty-Based Treatment Bias Impact Outcomes in CLTI?

What Impact Do Social Determinants Have on CLTI Care, and What Strategies Can Be Implemented for Improvement?

Addressing Regional Disparities to Improve Access to Care for CLTI Patients

Latest Advancements in the Best CLI-Basil Patient Journey

Implementation Science in PAD Intervention: Optimize PAD

Designing Future RCTs in PAD Intervention to Meaningfully Change Hard Endpoints - The "Just Give It" Approach

Insights from VOYAGER PAD on Anticoagulants in PVI Patients

Early Lipid Lowering Therapy and Glycemic Control Agents: What’s Their Benefit in PAD Intervention

Real World Data in PAD

Best CLI Medical Therapy Subgroup

Peerless Trial Pivotal Results

What am I Most Anticipating in Upcoming Clinical Trials?

Most Important Clinical Trial Endpoints to the PE Clinician in the Trenches

Peerless Digging Through the Supplement

Interpreting the PEERLESS Trial Through the Statistical Lens

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content